LIGANBOL - Keifei Pharma

Ligandrol (LGD-4033) represents a novel class of muscle-preserving compounds developed by Ligand Pharmaceuticals in the early 2010s. As a selective androgen receptor modulator (SARM), it was initially researched for treating conditions like muscle wasting and osteoporosis by targeting androgen receptors in muscle and bone tissues. Unlike traditional anabolic agents, it offers anabolic effects without significant androgenic risks. Despite gaining popularity in athletic circles, LGD-4033 remains a research compound with no official approval for medical use.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about LIGANBOL by Keifei Pharma, consult with your doctor or healthcare professional.